Differenzialdiagnose der Hämaturie

Horstmann, Marcus; Franiel, Tobias; Grimm, Marc‐Oliver

doi:10.1007/s00120-014-3506-4

Cited by 11 publications

(9 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Als Makrohämaturie bezeichnet man eine sichtbare Blutung aus den Harnwegen mit einem großen Spektrum an Schwere und Urinfarbe. Bereits 1 ml Blut genügt, um den Urin rötlich zu färben [14]. Im Extremfall kann es zu einer zunehmenden Koagelbildung (Harnblasentamponade) mit möglicher Harnverhaltung kommen.…”

Section: Makrohämaturieunclassified

“…Bei einer Hämoglobin-wirksamen Blutung kann zudem ein hämorrhagischer Schock auftreten [1]. Auch eine Myoglobinurie, eine Rifampicin-Therapie oder der Genuss besonderer Nahrungsmittel wie Rote Bete oder Heidelbeeren verursachen Urinverfärbungen und müssen in der Anamnese in Betracht gezogen werden [14]. Die gleichzeitige Einnahme blutverdünnender Medikamente ist oft Ursache rezidivierender und therapierefraktärer Makrohämaturien und sollte möglichst vorübergehend pausiert werden.…”

Section: Makrohämaturieunclassified

“…Die häufigste Quelle der Blutung liegt in der Harnblase oder in der Prostata, seltener in der Urethra oder im oberen Harntrakt [14]. Die Ursache kann andererseits entzündlich, traumatisch oder maligne sein.…”

Section: Makrohämaturieunclassified

“…Die sogenannte initiale Makrohämaturie zeigt sich am Beginn der Miktion, gefolgt von klarem Urin, und hat ihren Ursprung meist in der Urethra, der Prostata oder den Samenwegen. Eine terminale Hämaturie tritt dagegen erst am Ende der Miktion auf und spricht für eine Blutungsquelle am Blasenauslass [14]. Bei der totalen Makrohämaturie aus der…”

Section: Makrohämaturieunclassified

See 3 more Smart Citations

Urologische Notfälle

Simondi¹,

Aziz²

2021

Notfallmedizin up2date

View full text Add to dashboard Cite

Section: Makrohämaturieunclassified

See 2 more Smart Citations

Urologische Notfälle

Simondi¹,

Aziz²

2021

Notfallmedizin up2date

View full text Add to dashboard Cite

“…Gross haematuria de ned that the color change was observed in the appearance of urine, and con rmed by demonstration of red blood cells in the urinary sediment as shown by microscopy [13]. Microhaematuria de ned that 3 or more red blood cells per high-power microscopic eld in urinary sediment [14].…”

Section: Haematuria Detectionmentioning

confidence: 99%

The influence of haematuria on the utility of the BTA stat test in the diagnosis of bladder cancer: a prospective study

Xiong

Xiong³

et al. 2020

Preprint

View full text Add to dashboard Cite

Background: The urinary bladder tumour antigen (BTA) stat test has already been used for the diagnosis and monitoring of bladder cancer (BC). However, more evidence is needed regarding its efficacy and utility in the clinic. In this study, we investigated the influence of haematuria on the performance of the BTA stat test in a clinical cohort. Methods: Urine samples from 836 subjects, including 50 healthy volunteers, 553 patients with benign urologic disorders, 124 patients with histologically proven BC, and 109 patients with other histologically proven urologic cancers, were analysed by the BTA stat test and urinalysis. We detected the sensitivity and specificity of the BTA stat test in each group, and analysed the effect of haematuria on the specificity. Results: Our data showed that 58.06% of patients had haematuria in the BC group. Haematuria with benign prostatic hyperplasia (BPH), renal hamartoma (RH) and urolithiasis were identified in 39.01%, 42.86% and 66.49% of patients with benign urologic disorders, respectively. Haematuria was identified in 48.72% of prostatic cancer patients and 67.74% of renal cancer patients. The overall sensitivity of the BTA stat test was 90.32%. The sensitivity was 97.22% in BC patients with haematuria and 80.77% in BC patients without haematuria. The overall specificity in healthy individuals, patients with benign urologic disorders and other urologic cancers was 50.84%. In all patients with haematuria, the specificity of the BTA stat test was 15.82%, while it was 72.6% in patients without haematuria. Conclusions: Haematuria has a significant influence on the BTA stat test. Thus, this test should not be used for the diagnosis of bladder cancer in patients with haematuria.

show abstract

Fokale Therapie von kleinen Nierentumoren

Wendler

Friebe

Baumunk

et al. 2016

Urologe

View full text Add to dashboard Cite

Percutaneous radiofrequency ablation (RFA) and laparoscopic cryoablation are currently the most common treatment alternatives, although there are limitations particularly for renal tumors located centrally near the hilum. More recent ablation procedures such as high intensity focused ultrasound (HIFU), irreversible electroporation, microwave ablation, percutaneous stereotactic ablative radiotherapy and high-dose brachytherapy have high potential in some cases but are currently regarded as experimental for the treatment of renal cell carcinoma.

show abstract

Differenzialdiagnose der Hämaturie

Cited by 11 publications

References 19 publications

Urologische Notfälle

Urologische Notfälle

The influence of haematuria on the utility of the BTA stat test in the diagnosis of bladder cancer: a prospective study

Fokale Therapie von kleinen Nierentumoren

Contact Info

Product

Resources

About